Clinical significance of early circulating tumor cells (CTC) changes, analyzed by AdnaTest, in patients (pts) receiving first-line methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy (CT) for metastatic urothelial cancer (UC). (December 2016) - Necchi, A.; Fina, E.; Giannatempo, P.; Colecchia, M.; Raggi, D.; Daidone, M.G.; Cappelletti, V.